FDA.reportPublic FDA data

Scenesse 16 MG Drug Implant

RxCUI
2262259
RxNorm name
Scenesse 16 MG Drug Implant
Display name
Scenesse 16 MG Drug Implant
Full name
Scenesse 16 MG Drug Implant
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:09

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SCENESSEAFAMELANOTIDECLINUVEL INC.94f53286-11dd-7fbb-e053-2a95a90a7c482026-05-11Warnings, Adverse reactionsExact identifier
rxcui: 2262259

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
94f53286-11dd-7fbb-e053-2a95a90a7c48SCENESSE 16 MG Subcutaneous Drug Implant [PSN] · afamelanotide 16 MG Drug Implant [Scenesse] [SBD] · afamelanotide 16 MG (equivalent to 18 mg of afamelanotide acetate) Drug Implant [Scenesse] [SY] · Scenesse 16 MG Drug Implant [SY]411HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SCENESSE safely and effectively. See full prescribing information for SCENESSE. SCENESSE® (afamelanotide) implant, for subcutaneous use. Initial U.S. Approval: 201920260511